Revolution Medicines, Inc. Warrant (RVMDW)
USD 0.04
(-0.5%)
USD 0.04
(-0.5%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -399.66 Million USD | -91.17% |
| 2022 | 25.72 Million USD | 16.62% |
| 2021 | 22.05 Million USD | 124.71% |
| 2020 | -89.26 Million USD | -114.0% |
| 2019 | -41.71 Million USD | -326.69% |
| 2018 | 18.4 Million USD | 1648.91% |
| 2017 | -1.18 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -12.77 Million USD | 89.18% |
| 2024 Q1 | -118.02 Million USD | -5477.55% |
| 2023 Q1 | 4.48 Million USD | -64.8% |
| 2023 Q3 | -2.14 Million USD | -204.58% |
| 2023 Q2 | 2.05 Million USD | -54.23% |
| 2023 FY | 2.27 Million USD | -91.17% |
| 2023 Q4 | -2.11 Million USD | 1.35% |
| 2022 Q1 | 6.78 Million USD | 28.25% |
| 2022 FY | 25.72 Million USD | 16.62% |
| 2022 Q4 | 4.48 Million USD | -64.8% |
| 2022 Q2 | -66.09 Million USD | -1074.62% |
| 2022 Q3 | 12.73 Million USD | 119.26% |
| 2021 FY | 22.05 Million USD | 124.71% |
| 2021 Q4 | 5.28 Million USD | -28.52% |
| 2021 Q3 | 7.39 Million USD | 116.31% |
| 2021 Q2 | -45.37 Million USD | -21.84% |
| 2021 Q1 | -37.23 Million USD | -21.19% |
| 2020 Q2 | -22.21 Million USD | 2.98% |
| 2020 Q1 | -22.89 Million USD | -43.88% |
| 2020 FY | -89.26 Million USD | -114.0% |
| 2020 Q4 | -30.72 Million USD | -8.75% |
| 2020 Q3 | -28.25 Million USD | -27.22% |
| 2019 Q4 | -15.91 Million USD | -3.3% |
| 2019 FY | -41.71 Million USD | -326.69% |
| 2019 Q3 | -15.4 Million USD | -47.3% |
| 2019 Q2 | -10.45 Million USD | -33.44% |
| 2019 Q1 | -7.83 Million USD | 2.29% |
| 2018 Q4 | -8.02 Million USD | -2.37% |
| 2018 Q3 | -7.83 Million USD | 0.0% |
| 2018 FY | 18.4 Million USD | 1648.91% |
| 2017 FY | -1.18 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | 1151.056% |
| Alkermes plc | 1.37 Billion USD | 129.073% |
| Agenus Inc. | 139.61 Million USD | 386.262% |
| Aptorum Group Limited | -1.11 Million USD | -35754.338% |
| Ardelyx, Inc. | 106.66 Million USD | 474.705% |
| Dyadic International, Inc. | 922.95 Thousand USD | 43402.559% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 1997.65% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -228484.502% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -2891.979% |
| Novavax, Inc. | 639.93 Million USD | 162.454% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -753.272% |
| Pyxis Oncology, Inc. | -2 Million USD | -19883.2% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -77242.447% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 2198.745% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -904362.75% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -75737.571% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | -306.919% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 49933.416% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -487295.122% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 395.459% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 5177.678% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -312.237% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 126.33% |
| AlloVir, Inc. | -398 Thousand USD | -100318.09% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 266.018% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 94360.377% |
| Bicycle Therapeutics plc | -129.52 Million USD | -208.573% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 333153.333% |
| ChromaDex Corporation | 50.78 Million USD | 887.05% |
| Chimerix, Inc. | 324 Thousand USD | 123453.086% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -1182.304% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -415.044% |
| CRISPR Therapeutics AG | 240.95 Million USD | 265.866% |
| Precision BioSciences, Inc. | 40.47 Million USD | 1087.507% |
| Fate Therapeutics, Inc. | -98.16 Million USD | -307.143% |
| Fortress Biotech, Inc. | 57.85 Million USD | 790.827% |
| Fortress Biotech, Inc. | 57.85 Million USD | 790.827% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 2510.955% |
| ImmuCell Corporation | 4.39 Million USD | 9190.95% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | -276.605% |
| Immix Biopharma, Inc. | -5468.00 USD | -7309044.111% |
| Incyte Corporation | 3.44 Billion USD | 111.616% |
| Innoviva, Inc. | 261.06 Million USD | 253.09% |
| IO Biotech, Inc. | -756 Thousand USD | -52765.608% |
| Jaguar Health, Inc. | 7.72 Million USD | 5274.314% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -60090.361% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 433.74% |
| ContextLogic Inc. | 59 Million USD | 777.397% |
| MiMedx Group, Inc. | 266.84 Million USD | 249.775% |
| MEI Pharma, Inc. | 49.32 Million USD | 910.234% |
| NextCure, Inc. | -3.68 Million USD | -10748.643% |
| Onconetix, Inc. | -1.12 Million USD | -35357.453% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -1279.674% |
| Opthea Limited | 21.72 Thousand USD | 1840173.665% |
| Psyence Biomedical Ltd. | -240.00 USD | -166526566.667% |
| Vaxcyte, Inc. | -75 Million USD | -432.885% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -697077.546% |
| Precigen, Inc. | 106 Thousand USD | 377141.509% |
| Pharming Group N.V. | 220.1 Million USD | 281.58% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 77704.66% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 39709.911% |
| PureTech Health plc | -1.6 Million USD | -24832.252% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 464.086% |
| Avidity Biosciences, Inc. | -181.4 Million USD | -120.312% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -781.774% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -1717.729% |
| Acelyrin, Inc. | -115 Thousand USD | -347433.913% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -3976260.561% |
| Summit Therapeutics Inc. | -2.05 Million USD | -19395.805% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -69893.695% |
| Senti Biosciences, Inc. | -2.68 Million USD | -14796.161% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 9965.811% |
| Elevation Oncology, Inc. | -39 Thousand USD | -1024679.487% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -8229.804% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -10038.486% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 1472.048% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 80677.419% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -726561.818% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 483.927% |
| Seer, Inc. | 7.02 Million USD | 5787.548% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 9228.917% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 1955.02% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -337194.816% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -278798.263% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 65726.273% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 431.743% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 227.415% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -7993180.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 15626.962% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -787570.477% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 1460.003% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -172168.966% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -81132.52% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -5530.657% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -84120.464% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -3842823.077% |
| Soligenix, Inc. | 97.31 Thousand USD | 410807.936% |
| Century Therapeutics, Inc. | -10.8 Million USD | -3597.511% |
| Kura Oncology, Inc. | -849 Thousand USD | -46974.676% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -495.589% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -271780.272% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 503.542% |
| Autolus Therapeutics plc | -4.86 Million USD | -8111.712% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 1065.699% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -237795.238% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 521.929% |
| GRI Bio, Inc. | 10.84 Million USD | 3786.597% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 15834.89% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -4500.714% |
| IGM Biosciences, Inc. | -211.66 Million USD | -88.824% |
| INmune Bio, Inc. | 155 Thousand USD | 257947.742% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 745.254% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -26432.987% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -61533.362% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -1365152.442% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 99518.905% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -19923.246% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -127588.179% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 523.099% |
| Verastem, Inc. | -62 Thousand USD | -644519.355% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 16513.306% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -153027.969% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 13303.304% |
| Histogen Inc. | 3.76 Million USD | 10703.98% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 69464.555% |
| Surrozen, Inc. | -27.23 Million USD | -1367.734% |
| Organovo Holdings, Inc. | -5.38 Million USD | -7316.292% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -33070.44% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -1458.327% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 2093.138% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -20184950.505% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 6688.133% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -595249.391% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 358.196% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 274217.97% |
| Apollomics, Inc. | 127 Thousand USD | 314796.063% |
| Amarin Corporation plc | 165.54 Million USD | 341.429% |
| Mesoblast Limited | -9.81 Million USD | -3971.971% |
| Turnstone Biologics Corp. | 16.5 Million USD | 2521.326% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | -261.723% |
| Synaptogenix, Inc. | -6347.00 USD | -6296796.171% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -783554.902% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 347.677% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 122.738% |
| Better Therapeutics, Inc. | -2.72 Million USD | -14545.071% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | -256.331% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 218.215% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -3503266.059% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -6284.409% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -35970.758% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 5561.382% |
| Insmed Incorporated | 239.63 Million USD | 266.78% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 11270.039% |
| OmniAb, Inc. | 14.66 Million USD | 2824.92% |
| Alector, Inc. | -95.05 Million USD | -320.464% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 418.151% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -819.55% |
| Zai Lab Limited | 170.9 Million USD | 333.854% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 588.127% |
| Aura Biosciences, Inc. | -1.29 Million USD | -30762.085% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 307533.846% |
| Immunic, Inc. | -111 Thousand USD | -359957.658% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 2620.903% |
| Veracyte, Inc. | 248.14 Million USD | 261.059% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 94.282% |
| FibroGen, Inc. | 128.9 Million USD | 410.048% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -70862311.348% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -3325.627% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 111.76% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 102841.388% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 212.472% |
| TG Therapeutics, Inc. | 219.1 Million USD | 282.405% |
| Galecto, Inc. | -830 Thousand USD | -48052.289% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -28756.606% |
| Fortrea Holdings Inc. | 424 Million USD | 194.26% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -363.825% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -70387.478% |
| XBiotech Inc. | -1.74 Million USD | -22816.514% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -35970.758% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -760.029% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -429.118% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 644.479% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 2478.528% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 202.731% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -705.011% |
| Vaxxinity, Inc. | -2.23 Million USD | -17790.063% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 222.315% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -3429.403% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 1734.551% |
| NexImmune, Inc. | -1.02 Million USD | -38892.675% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 7401285.185% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -5524.59% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 103.536% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -597957.671% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -11154.97% |
| Ainos, Inc. | -253.73 Thousand USD | -157413.607% |
| Pluri Inc. | 322 Thousand USD | 124219.255% |
| Prothena Corporation plc | -129.2 Million USD | -209.335% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 892.608% |
| Celularity Inc. | 6.75 Million USD | 6016.566% |
| Rallybio Corporation | -150 Thousand USD | -266342.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | -1125.7% |
| MeiraGTx Holdings plc | 287 Thousand USD | 139355.749% |
| Omeros Corporation | -69.77 Million USD | -472.757% |
| Humacyte, Inc. | -76.55 Million USD | -422.095% |
| Immunocore Holdings plc | 248.39 Million USD | 260.901% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -2534.742% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 740.672% |
| Blueprint Medicines Corporation | 236.58 Million USD | 268.931% |
| CalciMedica, Inc. | -58 Thousand USD | -688975.862% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -27926.928% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 1475.543% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -13952.883% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -1194.878% |
| Pulmatrix, Inc. | -8.22 Million USD | -4762.092% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -34059.316% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -100066.416% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | -0.218% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 14499.271% |
| Cytokinetics, Incorporated | -322.59 Million USD | -23.891% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 46459.086% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -117103.519% |
| Vor Biopharma Inc. | -3.49 Million USD | -11345.132% |
| Roivant Sciences Ltd. | 109.23 Million USD | 465.875% |
| Evogene Ltd. | 1.39 Million USD | 28667.834% |
| ProKidney Corp. | -3.16 Million USD | -12511.676% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -810.148% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 5928.555% |
| CorMedix Inc. | -205.56 Thousand USD | -194325.04% |
| BioLineRx Ltd. | 1.1 Million USD | 36170.758% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -408.019% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -1211003.03% |
| Atai Life Sciences N.V. | -5000.00 USD | -7993180.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -327872.493% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -416216.667% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -28673.506% |
| Sagimet Biosciences Inc. | 2 Million USD | 20083.2% |
| MediciNova, Inc. | 979.7 Thousand USD | 40894.321% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -373.99% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -422578.864% |
| GeoVax Labs, Inc. | -20.72 Million USD | -1828.809% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 263.438% |
| Biomea Fusion, Inc. | -4.2 Million USD | -9413.544% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 145.815% |
| Mereo BioPharma Group plc | 7.42 Million USD | 5481.955% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -128823.871% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -3330433.333% |
| Absci Corporation | -41.84 Million USD | -855.014% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -7993180.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -423.305% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -16139.902% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 286.99% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -42372.264% |
| Allakos Inc. | -6.14 Million USD | -6408.126% |
| Imunon, Inc. | -720 Thousand USD | -55408.503% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -479.257% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 183.982% |
| BioAtla, Inc. | -103.73 Million USD | -285.289% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -3503266.059% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -224430.337% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | -64.593% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -128409.325% |
| XOMA Corporation | 3.86 Million USD | 10451.308% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -470.256% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 2801.528% |
| aTyr Pharma, Inc. | -2.38 Million USD | -16636.348% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 3307.576% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -1378051.724% |
| Viridian Therapeutics, Inc. | -1 Million USD | -39549.206% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 3074338561.538% |
| Akari Therapeutics, Plc | -4000.00 USD | -9991500.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 162.752% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 205363.266% |
| UroGen Pharma Ltd. | 73.35 Million USD | 644.858% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -1397.205% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 3442511.714% |
| Orgenesis Inc. | -5.72 Million USD | -6881.031% |
| Entera Bio Ltd. | -56 Thousand USD | -713585.714% |
| GH Research PLC | -315 Thousand USD | -126777.46% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -211362.434% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -76026.476% |
| Xencor, Inc. | -85.26 Million USD | -368.759% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -180762.262% |
| Replimune Group, Inc. | -2.65 Million USD | -14953.258% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -39817.063% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 324.727% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 205363.266% |
| Portage Biotech Inc. | -54 Thousand USD | -740018.519% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -422578.864% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -105911.671% |
| OncoCyte Corporation | 413 Thousand USD | 96870.944% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -8891201.446% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -180028728.829% |
| Purple Biotech Ltd. | -196 Thousand USD | -203810.204% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 4556.557% |
| scPharmaceuticals Inc. | 9.78 Million USD | 4185.708% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -3726.382% |
| HilleVax, Inc. | -2.15 Million USD | -18437.291% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -411924.742% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -2663616.342% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -59729.94% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -1737569.565% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -5324380.16% |
| Savara Inc. | -44.26 Million USD | -802.951% |
| Curis, Inc. | 9.81 Million USD | 4173.632% |
| Daré Bioscience, Inc. | 2.76 Million USD | 14530.793% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -320174.385% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -23015.327% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -175191.228% |
| BeiGene, Ltd. | 2.07 Billion USD | 119.225% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -14194.646% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 805.024% |
| Erasca, Inc. | -3.73 Million USD | -10609.11% |
| bluebird bio, Inc. | -4.03 Million USD | -9817.221% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -1416244.177% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 120.987% |
| DBV Technologies S.A. | 15.72 Million USD | 2641.099% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -1416244.177% |
| Moderna, Inc. | 2.15 Billion USD | 118.546% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -43579.126% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 5092.056% |
| Molecular Templates, Inc. | 50.39 Million USD | 893.063% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -74464.179% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 398.729% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -6323.401% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -915.845% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | -259.643% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -11038.907% |
| MacroGenics, Inc. | 50.52 Million USD | 890.991% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -6454.018% |
| Prime Medicine, Inc. | -147.9 Million USD | -170.217% |
| Aditxt, Inc. | -111.66 Thousand USD | -357829.429% |
| Adagene Inc. | 18.11 Million USD | 2306.687% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 81998.361% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 385.063% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 353.215% |
| SciSparc Ltd. | 2.19 Million USD | 18299.636% |
| Vericel Corporation | 135.57 Million USD | 394.79% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -1595428.764% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -1289887.735% |
| Generation Bio Co. | -73.91 Million USD | -440.737% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -91356.293% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 831.731% |
| Invivyd, Inc. | -2.02 Million USD | -19607.298% |
| Relay Therapeutics, Inc. | -300.84 Million USD | -32.849% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -386280.247% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 514.727% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 506.625% |
| ADMA Biologics, Inc. | 88.21 Million USD | 553.041% |
| Clene Inc. | 533 Thousand USD | 75083.865% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 1757.725% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -41662.173% |
| GeoVax Labs, Inc. | -20.72 Million USD | -1828.809% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 20203.823% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -205577.35% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 902.458% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -5535.42% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -47706.699% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 579.127% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 546746.241% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 851.785% |
| Verve Therapeutics, Inc. | -173.18 Million USD | -130.769% |
| Trevena, Inc. | 1.45 Million USD | 27568.316% |
| Surrozen, Inc. | -27.23 Million USD | -1367.734% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -113119.263% |
| Cingulate Inc. | -582.91 Thousand USD | -68462.645% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -1289138.71% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -1928.854% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -5279477.279% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -45264.813% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 158.713% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -40351.822% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -709253.591% |
| Kronos Bio, Inc. | 1.37 Million USD | 29230.029% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -644.725% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -136771.233% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -81745.698% |
| ImmunityBio, Inc. | -17.89 Million USD | -2134.008% |
| Korro Bio, Inc. | -3.63 Million USD | -10910.028% |
| Kineta, Inc. | 5.43 Million USD | 7456.23% |
| BioVie Inc. | -229.37 Thousand USD | -174138.917% |
| Codexis, Inc. | 57.33 Million USD | 797.08% |
| Celularity Inc. | 6.75 Million USD | 6016.566% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 10059.232% |
| Celcuity Inc. | -142.77 Thousand USD | -279831.639% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 790105.93% |
| Cibus, Inc. | 1.42 Million USD | 28205.767% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -106762.032% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -1643.811% |
| IN8bio, Inc. | -2.5 Million USD | -15880.168% |
| Kodiak Sciences Inc. | -25.94 Million USD | -1440.309% |
| Annexon, Inc. | -3.26 Million USD | -12133.364% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -19453.033% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -857.577% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 62547.5% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 151.337% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 331.08% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -20934.947% |
| Arcellx, Inc. | 108.27 Million USD | 469.106% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -1134.712% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 604.601% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -1789.486% |
| Moolec Science SA | -143.3 Thousand USD | -278790.478% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -844.43% |
| Geron Corporation | -123.5 Million USD | -223.607% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 12258.929% |
| Royalty Pharma plc | 1.79 Billion USD | 122.279% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -470.215% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -11064794.795% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 172822.362% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | -258.72% |
| Humacyte, Inc. | -76.55 Million USD | -422.095% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -42006.505% |
| 89bio, Inc. | -273 Thousand USD | -146297.07% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -31695.068% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -47030.189% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -324830.081% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 35816.175% |
| Notable Labs, Ltd. | 113 Thousand USD | 353784.956% |
| Liquidia Corporation | 14.6 Million USD | 2837.425% |
| Mustang Bio, Inc. | -2.22 Million USD | -17862.427% |
| Immunovant, Inc. | -231 Thousand USD | -172914.719% |
| Quantum-Si incorporated | 488 Thousand USD | 81998.361% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -619.351% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -1332113.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 21564.232% |
| Acasti Pharma Inc. | -11 Thousand USD | -3633209.091% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -195222.969% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -61533.362% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | -138.588% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 35325.722% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -104798.688% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -20311.849% |
| PepGen Inc. | -1.18 Million USD | -33655.405% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -314596.063% |
| United Therapeutics Corporation | 2.07 Billion USD | 119.307% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1645.486% |
| Solid Biosciences Inc. | -76.56 Million USD | -422.007% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -483854.325% |
| Immuneering Corporation | -764.13 Thousand USD | -52202.595% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 603238.959% |
| Belite Bio, Inc | -399 Thousand USD | -100066.416% |
| XOMA Corporation | 3.86 Million USD | 10451.308% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -1894.729% |
| Bionomics Limited | -434.44 Thousand USD | -91893.306% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -37112.663% |
| uniQure N.V. | 2.21 Million USD | 18143.521% |
| Cassava Sciences, Inc. | -89.42 Million USD | -346.936% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -334.092% |
| Forte Biosciences, Inc. | -9000.00 USD | -4440611.111% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -47763.952% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -91356.293% |
| Altimmune, Inc. | -65.37 Million USD | -511.359% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 210.395% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -37112.663% |
| Compugen Ltd. | 31.45 Million USD | 1370.59% |
| Peak Bio, Inc. | 367.76 Thousand USD | 108772.563% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 1730.217% |
| Benitec Biopharma Inc. | 108 Thousand USD | 370159.259% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -512289.744% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -33122.278% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -21835.456% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -335752.101% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -33122.278% |
| Instil Bio, Inc. | -4.75 Million USD | -8303.364% |
| argenx SE | 1.1 Billion USD | 136.055% |
| Immunome, Inc. | -8.9 Million USD | -4387.078% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -21046.243% |
| Verona Pharma plc | -679.62 Thousand USD | -58706.634% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -228279.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | -16657.4% |
| CervoMed Inc. | -1.29 Million USD | -30794.841% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -16504.238% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -8266.422% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 16274.18% |
| Moolec Science SA | -143.3 Thousand USD | -278790.478% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -97849.661% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -14860.128% |
| AnaptysBio, Inc. | 14.78 Million USD | 2803.904% |
| Design Therapeutics, Inc. | -537 Thousand USD | -74325.326% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -93498.126% |
| NeurAxis, Inc. | 2.15 Million USD | 18631.24% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 18723.672% |
| Lumos Pharma, Inc. | 2 Million USD | 20013.503% |
| Achilles Therapeutics plc | -4.73 Million USD | -8347.293% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -228279.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -378101.088% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 1362.412% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 46459.086% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -38627.132% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -777.457% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 929551.163% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -48520.925% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -3037322.101% |
| Palisade Bio, Inc. | 246 Thousand USD | 162565.041% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -1211003.03% |
| Beam Therapeutics Inc. | -59.67 Million USD | -569.768% |
| Neurogene Inc. | -3.26 Million USD | -12152.115% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 386.837% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -10725.135% |
| Sesen Bio, Inc. | 40 Million USD | 1099.16% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -134467.003% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -9824.518% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -4077.964% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 2938.523% |
| Athira Pharma, Inc. | -969 Thousand USD | -41144.995% |
| Vaccinex, Inc. | -16 Million USD | -2397.276% |
| HCW Biologics Inc. | -574.82 Thousand USD | -69428.064% |
| XOMA Corporation | 3.86 Million USD | 10451.308% |
| Nektar Therapeutics | 53.47 Million USD | 847.343% |
| Arvinas, Inc. | 71.8 Million USD | 656.635% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -378.863% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -536.661% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -124019.255% |
| Rezolute, Inc. | -36 Thousand USD | -1110077.778% |
| Clene Inc. | 533 Thousand USD | 75083.865% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -31126379.751% |
| BeyondSpring Inc. | 1.75 Million USD | 22924.9% |
| Synlogic, Inc. | -1.92 Million USD | -20672.557% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -1080072.973% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -6211.813% |
| Peak Bio, Inc. | 367.76 Thousand USD | 108772.563% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -2007.599% |
| Krystal Biotech, Inc. | 47.6 Million USD | 939.542% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 383.267% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 8053.512% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -15335.697% |
| MannKind Corporation | 136.19 Million USD | 393.458% |
| Ikena Oncology, Inc. | -50.49 Million USD | -691.539% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 467.291% |
| Gossamer Bio, Inc. | -4.38 Million USD | -9014.344% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -158496.825% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -7993180.0% |
| Legend Biotech Corporation | 140.92 Million USD | 383.592% |
| Mural Oncology plc | -2.56 Million USD | -15469.303% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -72434.301% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -399564.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 2025.72% |
| REGENXBIO Inc. | 53.02 Million USD | 853.671% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -7360.659% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -207652.567% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -22975.289% |
| Vaxart, Inc. | -60.76 Million USD | -557.742% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -151990.722% |
| Cellectis S.A. | 18 Thousand USD | 2220455.556% |
| Longeveron Inc. | 221 Thousand USD | 180943.439% |
| Repare Therapeutics Inc. | -80.07 Million USD | -399.143% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 136.566% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -30785.935% |
| Revolution Medicines, Inc. | -399.66 Million USD | -0.0% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -1141797.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 815740.816% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 104.643% |
| Denali Therapeutics Inc. | -93.34 Million USD | -328.158% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -1595428.764% |
| Veru Inc. | 7.56 Million USD | 5382.419% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -264578.146% |
| Cingulate Inc. | -582.91 Thousand USD | -68462.645% |
| Passage Bio, Inc. | -3.72 Million USD | -10640.769% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -3318265.991% |
| Exicure, Inc. | -1.42 Million USD | -27986.015% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -104250.914% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 14885.942% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -77856.6% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 686.654% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -267042.58% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -575.04% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 102315.857% |
| OmniAb, Inc. | 14.66 Million USD | 2824.92% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 2099.02% |
| Lipocine Inc. | -2.85 Million USD | -13919.274% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -21585.513% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -6905.504% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -26432.987% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 630.65% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -614767.692% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 574.12% |
| Ocugen, Inc. | -33.53 Million USD | -1091.711% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -12539.595% |
| Q32 Bio Inc. | 578 Thousand USD | 69246.021% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -150716.604% |
| Alumis Inc. Common Stock | -1.28 Million USD | -31026.48% |
| Equillium, Inc. | 35.95 Million USD | 1211.474% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -23313.24% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 79924.398% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -9667631.011% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -154210.425% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 94647.588% |
| Dominari Holdings Inc. | 2.03 Million USD | 19700.981% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -217734.971% |
| vTv Therapeutics Inc. | -13.59 Million USD | -2839.787% |
| Bio-Techne Corporation | 773.07 Million USD | 151.698% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 2407.662% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 186.735% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -34088.537% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -1566.656% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 3516.808% |
| Nkarta, Inc. | -5.86 Million USD | -6709.746% |
| BioCardia, Inc. | -7.24 Million USD | -5413.367% |
| Iterum Therapeutics plc | -1.75 Million USD | -22737.943% |